Registered title, quoted from ClinicalTrials.gov
TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
An open trial on stomach cancer, registered on ClinicalTrials.gov. Led by Affiliated Hospital of Qingdao University; 5 other hospitals on this site are listed as study sites.
Status, phase and start date as registered on ClinicalTrials.gov on 8 Nov 2026; the registry may have changed since. Whether someone can take part is decided by the study team. Not medical advice.
The study team’s contact details are on the registry record. This site does not pass on enquiries.
Hospitals in mainland China listed for this trial 6
Hospitals on this site that the registry record names as lead sponsor or study site, where the site is open. Lead sponsor first, then study sites A–Z.
- Lead sponsorAffiliated Hospital of Qingdao University青岛大学附属医院QingdaoHospital page
- Study sitePeking University People's Hospital北京大学人民医院BeijingHospital page
- Study siteQingdao Municipal Hospital青岛市市立医院QingdaoHospital page
- Study siteWeifang People's Hospital潍坊市人民医院WeifangHospital page
- Study siteWeihai Municipal Hospital威海市立医院WeihaiHospital page
- Study siteYantai Yuhuangding Hospital烟台毓璜顶医院YantaiHospital page
The record may name more sites, including outside mainland China, and sites can open or close during a trial. Full list of sites on ClinicalTrials.gov
Source: ClinicalTrials.gov record NCT07714980, read on 8 Nov 2026; hospital names matched to this site’s hospital list. How names are matched
Checklist for this trial 3
Only the points this trial’s record answers definitely: the registered age and sex, and criteria lines that state a number, score, stage or named test, quoted word for word. Tick a point once it has been compared with the medical records.
Show the checklist (3 points)Hide the checklist
18 years to 80 years; sex: all
Registered eligibility fields
Endoscopically and radiographically confirmed resectable stage I-III gastric cancer (AJCC 8th edition)
Inclusion criterion 2
Pregnancy or lactation
Exclusion criterion 7
Ticks stay on this page; they are not saved or sent. Meeting every point is not enough: the study team decides after its own screening. Lines that need the team’s judgement, such as “sufficient organ function”, are not in this list; they are in the full criteria below. Not stated definitely in this record: diagnosis and how it was confirmed; earlier treatment; day-to-day activity level; blood tests: counts, liver and kidney function; scans and measurable lesions; other conditions the trial excludes.
Questions to ask the study team
Picked from the record by fixed keyword rules (not by AI, not checked by hand) and quoted from ClinicalTrials.gov, NCT07714980, read on 10 Nov 2026.
Registered criteria
Quoted as registered on ClinicalTrials.gov, in English, read on 10 Nov 2026. This site has not checked, shortened or translated them. Meeting the written criteria is not enough: the study team decides after its own screening.
Inclusion Criteria:
- Age 18 to 80 years, both sexes
- Endoscopically and radiographically confirmed resectable stage I-III gastric cancer (AJCC 8th edition)
- Scheduled to undergo laparoscopic radical gastrectomy
- Willing to sign the informed consent form and able to comply with all study procedures
Exclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status ≥ IV
- Clinical stage IV gastric cancer
- Severe hepatic, renal, cardiovascular, or cerebrovascular diseases, or uncontrolled psychiatric disorders that may affect compliance or safety assessment
- Participation in another clinical trial or receipt of any form of acupoint stimulation (acupuncture, electroacupuncture, TEAS, etc.) within 1 month prior to enrollment
- Continuous use of opioids for more than 3 months prior to enrollment, with a daily dose ≥ 30 mg oral morphine equivalent
- Implanted cardiac pacemaker or other electronic stimulation device, or skin infection/lesion at the stimulation site
- Pregnancy or lactation
- Emergency surgery due to bleeding, perforation, obstruction, etc.
- Planned epidural anesthesia for the surgery
Quoted from ClinicalTrials.gov, NCT07714980, participation criteria. Read on 10 Nov 2026.
Where this information comes from
The registry record
ClinicalTrials.gov (US National Library of Medicine), record NCT07714980, read on 8 Nov 2026. A trial has a page here while its overall status is recruiting, not yet recruiting or enrolling by invitation and at least one listed hospital’s site is open. Trials registered only in China’s own registry (ChiCTR) are not included.
Diseases and hospitals
The trial is listed under a disease when this site’s ClinicalTrials.gov search for that disease in China returns it. Sponsor and site names in the record are matched to this site’s hospital list (ROR identifiers, checked aliases). Definitions
What is left out
Names of investigators and contact persons in the record, and anything not in the record. The title and criteria are quoted from the record.